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Age- and sex-related changes in fasting
plasma glucose and lipoprotein in
cynomolgus monkeys
Feng Yue1,2†, Guodong Zhang2,3†, Rongping Tang2,4, Zhouquan Zhang2, Liqiong Teng2 and Zhiming Zhang5*
Abstract
Background: The age-related dysfunction of glucose and lipid metabolism has a long-standing relationship with
cardiovascular and neurodegenerative disease. However, the effects of metabolic dysfunction on men and women
are different. Reasons for these sex differences remains unclear. Cynomolgus monkeys have been used, in the past,
for the study of human metabolic diseases due to their biologically proximity to humans. Nevertheless, few studies
to date have focused on both age- and sex-related differences in glucose and lipid metabolism. The present study
was designed to specifically address these questions by using a large cohort of cynomolgus monkeys (N = 1,399)
including 433 males and 966 females with ages ranging 4 to 24 years old.
Methods: Fasting plasma glucose (FPG) and lipid parameters including total cholesterol (T-Cho), triglyceride (TG),
high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were measured. All
these parameters were compared between ages and sexes.
Results: Among the entire cohort, age was strongly correlated with levels of FPG, TG and HDL. Consequently,
sex-related analysis revealed that females had significantly higher average levels of FPG, T-Cho, TG, HDL-C and
LDL-C than their male counterparts. In addition, more female (28.5 %) than male (16 %) monkeys qualified for
impaired fasting plasma glucose (IFPG). In those IFPG animals, sex-related differences were also detected i.e. females
had significantly increased levels of T-Cho, TG and LDL-C.
Conclusions: The result, for the first time, demonstrated the similarities and differences in detail between male and
female cynomolgus monkeys in relationship to age-related glucose and lipoprotein metabolisms, and differences
under various physiological conditions. The detailed glucose and lipoprotein profiling should provide additional and
important insights for prediabetic conditions. Cynomolgus monkeys appear to be an excellent model for
translational research of diabetes and for novel therapeutic strategies testing to overt diabetes.
Keywords: Aging, Diabetes, Lipoprotein, Glucose, Sex, Cynomolgus monkey
Background
National Diabetes Statistic Report 2014 reports that 37 % of
U.S. adults aged 20 years or older had prediabetes (51 % of
those aged 65 years or older). Applying this percentage
of the entire U.S. population in 2012 yields an estimat-
ed 86 million Americans aged 20 years or older
with prediabetes (http://119.90.25.23/www.cdc.gov/dia-
betes/pubs/statsreport14/nationaldiabetes-report-web.pdf).
The report also revealed that the number of people
with diabetes was 28.9 million in 2012, including the
4.3 million aged from 20–44, the 13.4 million from
45–64 and the 11.2 million from 65 years or older. If
the total number of people with diabetes was divided
by gender, men were 15.5 million and women were
13.4 million. In fact, among the 28.9 million people,
or 9.3 %, that make up the U.S. population that are
afflicted with diabetes, 8.1 million people are undiag-
nosed. Therefore, it is unclear how to prevent, best
manage and treat metabolic diseases, particularly how
to manage diabetes with multiple comorbidities and
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other geriatric complications [1, 2]. Nonhuman Primates
(NHPs) are increasingly used in scientific and translational
research mainly because of their similarity to humans in
physiology, neuroanatomy, reproduction, development,
cognition, and social complexity; thus confirming that one
can address questions using NHP models that cannot be
addressed using other species. For examples, cynomolgus
monkeys are well-characterized animal models for investi-
gating sex differences in susceptibility to diet-induced
atherogenesis [3]; and age-associated changes of amyloid-
β in cerebral spinal fluid [4].
Similar to humans, cynomolgus monkeys have an in-
creased propensity to developing diabetes, particularly
type 2 diabetes mellitus (T2DM) relative to increasing
age [5–7]. This natural occurrence of T2DM has been
reported in this kind of old-world primate by different
laboratories in the past [8–11]. However, prediabetic
conditions, which are associated with increased health
risks, have been under investigation especially with a
large cohort. Age- and sex-associated differences in fast-
ing plasma and lipoproteins have not been described in
detail in particular in nonhuman primates. The third
guideline from the Adult Treatment Panel of the US
National Cholesterol Education Program (ATP-III) rec-
ommends a full fasting lipoprotein profile, including tri-
glyceride (TG), total cholesterol (T-Cho), high-density
lipoprotein cholesterol (HDL-C), and low-density lipo-
protein cholesterol (LDL-C) [12].
The present study was designed to characterize age-
and sex-related changes in FPG and fasting lipoprotein
in large groups of male and female cynomolgus monkeys
with age raging from 2–24 years old. In humans, it is a
challenge to study age- and sex-related differences due
to the presence of multiple confounders that may dir-
ectly or indirectly impact upon the outcome such as life
style, dietary composition, physical activity etc. In non-
human primates, they live in a laboratory-controlled en-
vironment provide a milieu where most of these factors
are absent or tightly regulated particularly the daily diet
and food supplement. Since cynomolgus monkeys are
likely to provide an excellent model for studying predia-
betic and diabetic conditions; results from the present
study could supply important insights for novel drug
testing designed to specifically address prediabetic con-
dition, which is a factor for health.
Methods
Animals
Blood samples were randonmly collected from 1,399 cy-
nomolgus monkeys (Macaca fascicularis) from a com-
mercial vendor (Grandforest Primate Breeding Co. Ltd.,
Guangxi, China) during the past 3–4 years. They in-
cluded 433 males and 966 females with ages ranging
from 4 to 24 years old. Body weights at the time of
sampling were ranging from 2.2 to 13.86 (mean =
5.34 ± 1.96) kilograms. Prior to each sampling sessions,
informed consent from the vendor was obtained, and all
procedures were conducted in compliance with animal
care and use protocols. The animals were housed out-
doors in big cages (9–15 animal/cage) and were fed a
custom-in-house made pellet which is grain-based diet
that contains ~ 20 % protein, ~5 % fat, and 8.5 % fi-
bers and the remaining as carbohydrate and minerals
at 150 g/monkey/day along with water available ad
libitum,. In addition, all monkeys are supplemented
with fresh fruits and vegetables which are rich source
of vitamin C. The study protocol was reviewed and finally
approved by the Institutional Animal Care and Use Com-
mittee (IACUC) of Wincon TheraCells Biotechnologies
Co., Ltd. (Wincon) in Nanning Guangxi China, which is
fully accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care (AAALAC).
Animal husbandry
Cynomolgus monkeys used for this project were regu-
larly group-housed outdoors in 15 m × 24 m open pens
with 8 separate covered feeding stations to facilitate food
and supplement accessibility. The animals were trans-
ferred from outdoors facility to single primate cage with
the dimension of 28 in. depth, 39 in. width and 33 in.
height for each cage, and were acclimated for at least
48 h after transfer. Leftover monkey chow was cleared
from each cage before 18:00 PM, and blood sampling
started after 8:00 AM the next morning.
Blood sample and measurement
After the 14-h fasting, animals were anesthetized with
10 mg/kg ketamine and weighted after complete sedation.
Four-microliters of blood was obtained from the femoral
vein either in the left or right leg with a 20-gauge syringe,
and transferred into an EDTA anticoagulant tube for each
animal by well-trained lab technicians. The blood was im-
mediately centrifuged at 3,000 rpm for 15 min, and the
plasma was then stored at -20C°, which was then analyzed
within 48 h. After sampling, most animals were put back
to their group colony however a few were taken to the pri-
mate facility of Wincon to avoid desertion and inapt to
the original groups.
Fasting plasma glucose (FPG), total cholesterol (T-Cho),
triglyceride (TG), HDL-C and LDL-C were measured
using the Hitachi 7600 Biochemical Analyzer (Hitachi
Ltd., Tokyo, Japan) in a clinical laboratory, which is an af-
filiated hospital of Guangxi Medical University. All assay
kits were manufactured by Shanghai Zhicheng Biological
Technology Co., Ltd., FPG concentrations were measured
using GOD-PAP method; Fasting T-Cho concentrations
were measured using CHOD-PAP method; Fasting TG
concentrations were measured using GPO-PAP method
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and Fasting HDL-C and LDL-C concentrations were mea-
sured using direct clearance method.
Statistical analysis
All data was analyzed using Prism 6 GraphPad Software
(San Diego, CA) and presented as mean ± SEM. The
distribution of age was assessed by a one-way analysis
of variance (ANOVA), followed by a multiple compar-
isons test. For normal Gaussian distribution, a one-
way ANOVA was followed by Holm-Sidak’s multiple
comparisons test; if normal distribution did not occur
it was followed by Kruskal-Wallis test which is then
followed by Dunn’s multiple comparisons test. In
multivariate analyses, linear regression and/or Pearson
Correlation for Gaussian distribution) or Spearman
(for nonparametric) correlation coefficients (r) were
used to describe the association between independent
variables of interest. Differences between male and fe-
male were analyzed by unpaired student t-test or
Mann-Whitney test (nonparametric test). A P value
<0.05 was considered statistically significant for all
analyses.
Results
Age-related differences
The average age of the cohort of animals was 13.74 ± 0.1
(Mean ± SEM) years old (Fig. 1a). Females (14.1 ± 0.11)
were ~2.3 years older than males (11.8 ± 0.17) (Fig. 1b).
When dividing animals by sex and their levels of FPG
showed no difference between normal, IFPG and dia-
betic male animals. By contrast, significant differences
between the normal and IFPG, and normal and dia-
betic animals were found in female monkeys (Fig. 1c).
The age-related changes with metabolic parameter
were summarized in Table 1. Examples of those cor-
relations analyzed with linear regression were shown
in Fig. 2.
Glucose and lipid profiles
Ages were highly correlated with FPG (Fig. 2b, Table 1).
According to the American Diabetes Association plasma
glucose level criteria for normal humans (Diabetes care.,
2003), was identified as < 4.4 mmol/L, impaired fasting
plasma glucose (IFPG) as 4.4-6.99 mmol/L and diabetic
as > 6.99 mmol/L. Based on this diagnostic criteria, 1,003
out of 1,399 (~71.7 %) were qualified as normal, 344 out
1,399 (~24.6 %) were IFGP and 47 out of 1,399 (~7 %)
were diabetic. Remarkably, some IFPG monkeys were as
young as 4 years old, although most IFPG animals were
found between 15–20 years old (Fig. 2b). Other more in-
teresting correlations included ages that were positively
correlated with levels of TG while negatively with levels
of HDL-C (Fig. 2c, d). No changes were found in levels
of T-Cho and LDL-C over aging (Table 1).
Sex-related differences
Male’s body weights were significantly (P < 0.001)
heavier than the female’s on the average (Fig. 3a). In
males, body weights increased with aging (Fig. 3b)
while virtually no changes were seen in females
(Fig. 3c). However, the overall correlation between
age and body weight in this cohort of monkeys
showed a slightly downward trend (r = −0.08, P = 0.0013)
(Table 1). Established data suggest that the normal
weight of cynomolgus monkeys are between 3.5 and
9Kg for males and 3 and 6Kg for females, which was
displayed in the current study [13]. Based on the
standard, the percentage of over-weighted animals
was 12.4 % in males and 13.5 % in females respect-
ively (Fig. 3b, c).
Fig. 1 Age distribution and associated differences
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Glucose and lipid profiles
Among this cohort of animals, females depicted higher
levels of all measured parameters including FPG, T-Cho,
TG, HDL-C and LDL-C than male monkeys (Fig. 4a-e).
If a focus was aimed to levels of FPG, in particular, it
would not be difficult to identify more female monkeys
qualified with IFPG and diabetes in percentage than
their male counterparts (Fig. 4f ). When comparing be-
tween normal and overweight animals, no statistical sig-
nificances were found in age and FPG (Fig. 5a, b).
If the focus was in between normal and IFPG animals,
as summarized in Table 2, several major findings be-
tween sexes under the two physiological conditions
were: 1) no statistical significance was found in levels of
FPG between normal male and female or between IFPG
male and female monkeys; 2) higher levels of T-Cho, TG
and LDL-C were found in female monkeys under both
normal and IFPG conditions than those of the males; 3)
higher level of HDL-C were found in the normal females
than that of the males; while no differences were found
between IFPG male and female monkeys.
When comparing between normal and over-weight
monkeys, levels of TG were significantly higher in over-
weight for both male (P < 0.01) and female (P < 0.001)
monkeys (Fig. 5d. Contrarily, significantly lower levels of
HDL-C (P < 0.05 for both sexes) and LDL-C (P < 0.05 for
male and P < 0.0001 for female) were found in over-
weight animals (Fig. 5e, f ); and lower levels of T-Cho
(P < 0.0001) were only seen in female over-weight ani-
mals (Fig. 5c).
When comparing between physiological conditions,
the most notable differences were the levels of TG
Table 1 Pairwise correlations (n = 1,399)
Age BW T-Cho TG HDL-C LDL-C FPG
r P value r P value r P value r P value r P value r P value r P value
Age −0.08 0.0013 −0.005 0.89 0.26 <0.0001 −0.12 <0.0001 0.012 0.67 0.17 <0.0001
BW −0.08 0.0013 −0.27 <0.0001 0.045 0.097 −0.14 <0.0001 −0.26 <0.0001 −0.11 <0.0001
T-Cho −0.005 0.89 −0.27 <0.0001 0.13 <0.0001 0.715 <0.0001 0.75 <0.0001 0.115 <0.0001
TG 0.26 <0.0001 0.045 0.097 0.13 <0.0001 −0.175 <0.0001 −0.019 0.45 0.28 <0.0001
HDL-C −0.12 <0.0001 −0.14 <0.0001 0.715 <0.0001 −0.175 <0.0001 0.43 <0.0001 0.015 0.55
LDL-C 0.01 0.67 −0.26 <0.0001 0.75 <0.0001 −0.019 0.45 0.43 <0.0001 0.04 0.101
FPG 0.17 <0.0001 −0.11 <0.0001 0.115 <0.0001 0.28 <0.0001 0.015 0.55 0.04 0.101
Pearson correlation was used with two-tailed P value. BW body weight, T-Cho total cholesterol, TG triglyceride, HDL-C total high-density lipoprotein, LDL-C total
low-density lipoprotein, FPG, fasting plasma glucose
Fig. 2 Age-associated changes in FPG and lipids
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particularly in female animals, i.e. the highest levels of
TG was observed in diabetic females followed by IFPG
animals (Fig. 6d right three columns). In males, the sig-
nificant differences were only seen between normal and
diabetic animals (Fig. 6d left three columns). Another in-
teresting discovery occurred in the diabetic female mon-
keys, it was found that they had the lowest level of
HDL-C, in which the difference between female IFPG
and diabetic monkeys was significant (P < 0.05) (Fig. 6e
left two columns). No statistical significances were found
in levels of T-Cho and LDL-C in male and female under
the three conditions (Fig. 6c, f ).
Discussion
The result of the present study and others suggest that
glucose metabolism slows with the aging process, which
could lead to diabetes mellitus. More diabetic and IFPG
monkeys were found in older and over-weight animals,
although IFPG animals could be also seen in the younger
cohorts. In humans, studies have found the impaired
glucose tolerance occurs in approximately 25 % of
people 65 years and older [14, 15]. The data from the
current study also indicated that changes in FPG were
not only age-dependent but also sex-dependent as well.
More IFPG and diabetic female cynomolgus monkeys
were found than their male counterparts. In this large
cohort of monkey, it was more surprisingly seen as
young as in 4 years old. Both sexes had elevated plasma
glucose levels, which qualified as IFPG; this is equivalent
to 12–16 years old human teenagers. The result appar-
ently had agreements with some human studies, which
have reported that the glucose tolerance decreases with
advancing age. The primary cause of this age-related
IFPG could be a result from tissue unresponsiveness to
insulin [5, 16, 17].
The strength of the present study was using a large co-
hort of animals to examine age-related changes in the
FPG; along with demonstrating that age- and sex-
dependent factors can change FPG levels. However, the
result was not supported by all nonhuman primate stud-
ies. For examples, Tigno and colleagues, on one hand,
reported that FPG among the non-diabetic animals
remained practically unchanged; indicating no age-
associated changes in the FPG were seen in their study
[18]. However, they found correlations between age and
2-h post oral glucose tolerance test (OGTT) and
hemoglobin A1C (HbA1C) levels. The present study was
focused on the fasting plasma glucose and not only
found age-associated changes in FGP but also found the
impaired FPG could occur even in as young as 4 years
old monkeys, which was equivalent 12–16 years old hu-
man teenagers. Nevertheless, the overall result from the
current study suggested that age is an independent fac-
tor for impaired fasting plasma glucose, which was inline
with previous studies in human and nonhuman pri-
mates. Thus suggesting dysfunction of glucose metabo-
lisms is one of the most common pathologies in aging
humans [19] and NHPs [20].
One weakness of the present study was to find
enough age-matched male cynomolgus monkeys to
match the number of females used in the study due
to the availability of older male monkeys. This could
be the reason that more IFPG and diabetic female
monkeys were identified. Other potential explanation
may be due to sex differences in hormonal patho-
physiology. A line of evidence suggests that T2DM af-
fects women disproportionately to men [21]. Women
with T2DM generally have poorer glycemic control
and are less likely to reach the goals for hemoglobin
A1c (HbA1c) compared with men. Women with dia-
betes have higher all-cause mortality [22–24].
Fig. 3 Sex-related differences in bodyweight
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Sex-related differences in levels of FPG were also
found in nonhuman primates [7]. On the other hand,
some community-based, cross-sectional studies revealed
slightly different results. For example, a study conducted
in Mauritius found that the prevalence of diabetes and
the prevalence of coexisting IFPG and IGT (impaired
glucose tolerance) were similar among men and women
[25]. In addition, IFPG was found to be more common
in men than in women; whereas IGT less common in
men than in women [26].
The results from the present study further confirmed
that some physiological measures change with age pri-
marily including body weight, levels of TG, HDL-C and
FPG. In fact, it has been known for decades that humans
have plasma lipids changes that correlate with age that
occur in both males and females [27]. Although the
underlying reasons for the age-related changes are not
completely delineated, several putative mechanisms have
been proposed. For example, in rodents TG absorption
can be impaired by as much as 50 % with advancing age;
suggesting that aging is associated with changes in the
absorptive capacity of the small intestine [28]. It could
also suggest a decrease in TG absorption that could be
underpinned by a decline in the secretion rate of the key
digestive enzyme pancreatic lipase [29]. The current data
agreed with some human studies in which the TG con-
centrations increase progressively in men, reaching peak
values between 40 and 50 years, and decline slightly
thereafter. In women, the TG concentrations increase
throughout their life, and are higher in those using es-
trogens constantly [30]. Human and nonhuman primate
studies reveal a trend in higher TG levels along with
lower HDL-C levels correlate with aging. In fact, highest
levels of fasting TG and lowest levels of HDL-C have
long be regarded as potent cardiovascular risk factor in
patients with and without diabetes mellitus [31–34].
Almost all lipoprotein levels, including HDL-C, are
much lower at birth than at adolescence and increase
during childhood [17]. HDL-C cholesterol in adults was
shown to decrease with age in both men and women in
prospective studies, most likely attributed to hormonal
changes [35, 36]. Baggio and coworkers reported that
the mean HDL levels of (both female and male) cente-
narians are 20 % lower than those of 65-year-old
subjects [37]. On the other hand, older people and cen-
tenarians are unlikely to have very low levels of HDL;
while mean HDL cholesterol levels did not vary or even
increase with age in cross-sectional studies [38]. Decline
in fasting HDL plasma concentration along with aging
was found among all tested animals in the present study.
Therefore, a negative and weak correlation between age
and HDL-C was significant (P < 0.0001). Also in the
present study, decline in levels of HDL-C appeared
more sharply in male (r2 = 0.13, P < 0.0001) than fe-
male (r2 = 0.007, P = 0.0063) monkeys.
The relationship between lipid profile alarm and
diabetes-associated complications has long been an area
of interest due to the fact that diabetes can impair the
utilization of lipids and lipoproteins which cause athero-
genic dyslipidemia. This is one of the most important
risk factors for the development of atherosclerosis in
diabetic individuals [39, 40]. Dyslipidemia is a potent
predictor of cardiovascular morbidity and mortality in dia-
betic patients. Based on American Diabetes Association
(ADA) Standards [41], diabetic dyslipidemia is character-
ized by increased serum LDL, TG and decreased HDL. In
Fig. 4 Sex-associated differences in FPG and lipids
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Fig. 5 Differences between normal and overweight animals
Table 2 Differences between normal and IFPG animals
Normal IFPG Difference
Male Female P value Male Female P value P value1 P value2
(N = 357) (N = 648) (N = 69) (N = 275)
Age (years) 11.91 ± 0.18 13.72 ± 0.14 **** 11.32 ± 0.48 14.76 ± 0.21 **** ns **
BW (Kg) 7.14 ± 0.08 4.58 ± 0.08 **** 7.12 ± 0.24 4.53 ± 0.08 **** ns ns
FPG (mmol/L) 3.38 ± 0.03 3.45 ± 0.02 ns 5.02 ± 0.07 5.16 ± 0.04 ns **** ****
T-Cho (mmol/L) 2.15 ± 0.02 2.52 ± 0.03 **** 2.27 ± 0.06 2.63 ± 0.04 *** ns ns
TG (mmol/L) 0.65 ± 0.02 0.86 ± 0.05 **** 0.77 ± 0.07 1.01 ± 0.04 ** ns ****
HDL-C (mmol/L) 1.14 ± 0.02 1.22 ± 0.02 * 1.24 ± 0.05 1.31 ± 0.03 ns ns ns
LDL-C (mmol/L) 0.85 ± 0.02 1.07 ± 0.02 **** 0.85 ± 0.03 1.12 ± 0.03 *** ns ns
Results are presented as mean ± SEM. Kruskal-Wallis test followed by Dunn’s multiple comparison test. ns, not significant. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****,
P < 0.0001. BW body weight, FPG fasting plasma glucose, T-Cho total cholesterol, TG total triglyceride, HDL-C total high-density lipoprotein, LDL-C total
low-density lipoprotein
1. Comparing between normal and IFPG in males
2. Comparing between normal and IFPG in females
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this study, increased serum levels of TG were found in
IFPG animals as compared with normal animals in both
sexes; while a significantly decreased HDL-C was only
seen in diabetic female monkeys. Overall results from the
present study suggest that increases of serum lipoprotein
along with aging were seen in both male and female ani-
mals in particular animals with elevated blood glucose. In
a recent published study, Ali et al. reported that individ-
uals with both diabetes and atherosclerosis had high levels
of TC, TG, LDL, VLDL (very low-density lipoprotein) and
low level of HDL in comparison to non-diabetic athero-
sclerotic and normal control individuals without any gen-
der differences observed. Among all three age groups,
lipoprotein abnormality was observed to be more frequent
in females than in males [42].
This study for the first time highlighted age- and sex-
effects on fasting plasma glucose and emphasized the rela-
tionship between elevated plasma glucose and lipid
profiles in both male and females. The comparison of fast-
ing plasma glucose and lipid profile in normal, IFPG and
diabetic animals; and also age-associated differences be-
tween males and females, provide important information;
such as IFPG can be found in cynomolgus monkeys in
both male and female as young as 4 years old, even though
they maintain normal body weight, and the relationship
between FPG and TG. The nonhuman primate data being
inline with some findings in humans indicates females are
more prone to have elevated plasma glucose and fasting
T-Cho, TG and LDL-C. However, female monkeys have
higher levels of HDL-C compared with males as well. The
overall result suggests cynomolgus monkey with naturally
spontaneous elevated plasma glucose and lipoprotein
levels, in particular, are useful models to study human
metabolic syndromes and have the potentially to be used
for screening new therapeutic strategies for treatment for
T2DM and other metabolic diseases.
Fig. 6 Sex-related differences between normal, IFPG and diabetic animals
Yue et al. Lipids in Health and Disease  (2016) 15:111 Page 8 of 10
Conclusions
The result, for the first time, demonstrated the similar-
ities and differences in detail between male and female
cynomolgus monkeys in relationship to age-related glu-
cose and lipoprotein metabolisms, and differences under
various physiological conditions. The detailed glucose
and lipoprotein profiling should provide additional and
important insights for prediabetic conditions. Cynomol-
gus monkeys appear to be an excellent model for trans-
lational research of diabetes and for novel therapeutic
strategies testing to overt diabetes.
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